Stem cell trial halted due to poor economic situation

16 Nov 2011
  • print

Geron, a California-based company that develops stem cell therapies, has decided to halt the world's first trial using human stem cells in patients due to financial constraints and the current economic situation.

 

Read more.

 

Comments

No comments made yet. Be the first to submit a comment

Leave your comment

Guest 25 May 2012